Dr Reddy’s Is Latest Rumored Buyer For Biogen’s Biosimilars
Reports Suggest Firm Has Thrown Its Hat Into The Ring, Following Samsung Bioepis And Intas
With Biogen having put its biosimilars interests on the market, multiple bidders appear to be interested in the business. Dr Reddy’s has become the latest firm to be named in media reports as vying for a deal.
